Slama et al. (2016) recently published a paper on issues relevant to setting regulations for endocrine disrupting substances in the European Union.1 The authors discuss options associated with these issues, briefly described as use of interim criteria, or use of the World Health Organization definition of endocrine disruption by itself or with additional categories of strength of evidence or chemical potency.
↧
